Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regulation of atherogenesis by chemokine receptor CCR6.

Literature DB >> 22732549

Regulation of atherogenesis by chemokine receptor CCR6.

Abstract

Atherosclerosis is a complex vascular pathology characterized in part by accumulation of innate and adaptive inflammatory cells in arterial plaque. Molecular mediators responsible for inflammatory cell accumulation in plaque include specific members of the chemokine family of leukocyte chemoattractants and their G protein-coupled receptors. Studies using the ApoE knockout mouse model have recently implicated chemokine receptor Ccr6 and its ligand Ccl20 as a nonredundant ligand-receptor pair in atherosclerosis, potentially operating at several stages of cell recruitment and on several leukocyte subtypes. Published by Elsevier Inc.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 22732549 PMCID： PMC3384481 DOI： 10.1016/j.tcm.2012.04.003

Source DB: PubMed Journal: Trends Cardiovasc Med ISSN： 1050-1738 Impact factor: 6.677

40 in total

Review 1. T cells in atherogenesis: for better or for worse?

Authors: Anna-Karin L Robertson; Göran K Hansson
Journal: Arterioscler Thromb Vasc Biol Date: 2006-09-14 Impact factor: 8.311

2. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

Authors: Marie Le Borgne; Nathalie Etchart; Anne Goubier; Sergio A Lira; Jean Claude Sirard; Nico van Rooijen; Christophe Caux; Smina Aït-Yahia; Alain Vicari; Dominique Kaiserlian; Bertrand Dubois
Journal: Immunity Date: 2006-02 Impact factor: 31.745

Review 3. IL-17 and Th17 Cells.

Authors: Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal: Annu Rev Immunol Date: 2009 Impact factor: 28.527

Review 4. CCR6 as a possible therapeutic target in psoriasis.

Authors: Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal: Expert Opin Ther Targets Date: 2010-09 Impact factor: 6.902

Review 5. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.

Authors: Iain Comerford; Mark Bunting; Kevin Fenix; Sarah Haylock-Jacobs; Wendel Litchfield; Yuka Harata-Lee; Michelle Turvey; Julie Brazzatti; Carly Gregor; Phillip Nguyen; Ervin Kara; Shaun R McColl
Journal: Bioessays Date: 2010-10-15 Impact factor: 4.345

Review 6. The CC chemokine CCL20 and its receptor CCR6.

Authors: Evemie Schutyser; Sofie Struyf; Jo Van Damme
Journal: Cytokine Growth Factor Rev Date: 2003-10 Impact factor: 7.638

7. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation.

Authors: F Sallusto; P Schaerli; P Loetscher; C Schaniel; D Lenig; C R Mackay; S Qin; A Lanzavecchia
Journal: Eur J Immunol Date: 1998-09 Impact factor: 5.532

Review 8. Immune and inflammatory mechanisms of atherosclerosis (*).

Authors: Elena Galkina; Klaus Ley
Journal: Annu Rev Immunol Date: 2009 Impact factor: 28.527

Review 9. Chemokines: established and novel targets in atherosclerosis.

Authors: Rory R Koenen; Christian Weber
Journal: EMBO Mol Med Date: 2011-10-28 Impact factor: 12.137

10. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.

Authors: M C Dieu; B Vanbervliet; A Vicari; J M Bridon; E Oldham; S Aït-Yahia; F Brière; A Zlotnik; S Lebecque; C Caux
Journal: J Exp Med Date: 1998-07-20 Impact factor: 14.307

5 in total

Regulation of atherogenesis by chemokine receptor CCR6.

Review 1. T cells in atherogenesis: for better or for worse?

2. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

Review 3. IL-17 and Th17 Cells.

Review 4. CCR6 as a possible therapeutic target in psoriasis.

Review 5. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.

Review 6. The CC chemokine CCL20 and its receptor CCR6.

7. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation.

Review 8. Immune and inflammatory mechanisms of atherosclerosis (*).

Review 9. Chemokines: established and novel targets in atherosclerosis.

10. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.

1. Inhibition of perilipin 2 expression reduces pro-inflammatory gene expression and increases lipid droplet size.

Review 2. Regulation of atherogenesis by chemokines and chemokine receptors.

3. Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.

Review 4. The role of chemoattractant receptors in shaping the tumor microenvironment.

5. Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins.